Manage Consent To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not…
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Accept Deny View preferences Save preferences
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Accept Deny View preferences Save preferences
Skip to content
Mechelen, Belgium; October 8, 2026, 22.01 CET; regulated information – Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) received a transparency notification from Bank of America.
Pursuant to Belgian transparency legislation1, Lakefront received a transparency notification, from Bank of America Corporation on October 6, 2026. The notification indicates that Bank of America Corporation, as controlling entity, crossed below the threshold of 10% of Lakefront’s voting rights on October 2, 2026, following a disposal of Lakefront voting rights and equivalent financial instruments.
On October 2, 2026, Bank of America Corporation (taking into account the holding of its affiliates) owned 254,604 voting rights and 5,371,394 equivalent financial instruments, representing together 8.54% of Lakefront’s currently outstanding 65,897,071 shares.
Summary of the transaction:
| Date on which the threshold was crossed | Date of notification | Direct voting rights after the transaction | Equivalent financial instruments after the transaction | Total (%) voting rights |
| October 2, 2026 | October 6, 2026 | 0.39% | 8.15% | 8.54% |
Content of the notification from Bank of America Corporation:
The notification dated October 6, 2026, contains the following information:
• Date of notification: October 6, 2026
• Date on which the threshold is crossed: October 2, 2026
• Threshold of voting rights crossed (in %): 10%
• Notification by: Bank of America Corporation
• Denominator: 65,897,071
• Reason for the notification: Acquisition or disposal of voting securities or voting rights
• Notified details:
| A) Voting Rights | Previous notification | After the transaction |
| | # of voting rights | # of voting rights | % of voting rights |
| Holder of voting rights | | Linked to securities | Not linked to securities | Linked to securities | Not linked to securities |
| Bank of America Corporation | 0 | 0 | | 0.00% | |
| Bank of America, National Association | 10,701 | 13,099 | | 0.02% | |
| Merrill Lynch International | 0 | 0 | | 0.00% | |
| BofA Securities, Inc. | 1,407,905 | 240,920 | | 0.37% | |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | 462 | 462 | | 0.00% | |
| U.S. Trust Company of Delaware | 76 | 123 | | 0.00% | |
| Subtotal | 1,419,144 | 254,604 | | 0.39% | |
| | TOTAL | 254,604 | 0 | 0.39% | 0.00% |
| B) Equivalent financial instruments | After the transaction |
| Holder of equivalent financial instruments | Type of financial instrument | Expiration date | Exercise period or date | # of voting rights that may be acquired if the instrument is exercised | % of voting rights | Settlement |
| Merrill Lynch International | Right to Recall | | | 369,629 | 0.56% | physical |
| Merrill Lynch International | Rights of Use | | | 7,060 | 0.01% | physical |
| BofA Securities, Inc. | Rights of Use | | | 4,821,751 | 7.32% | physical |
| BofA Securities, Inc. | Right to Recall | | | 39,143 | 0.06% | physical |
| Bank of America, National Association | Swaps | 15/10/2027 | | 2,013 | 0.00% | cash |
| Bank of America, National Association | Swaps | 15/06/2027 | | 13,443 | 0.02% | cash |
| Bank of America, National Association | Swaps | 31/07/2028 | | 3,327 | 0.01% | cash |
| Merrill Lynch International | Swaps | 15/01/2027 | | 11,812 | 0.02% | cash |
| Merrill Lynch International | Swaps | 30/04/2027 | | 85,549 | 0.13% | cash |
| Merrill Lynch International | Swaps | 15/06/2027 | | 13,443 | 0.02% | cash |
| Merrill Lynch International | Swaps | 01/11/2027 | | 557 | 0.00% | cash |
| Merrill Lynch International | Swaps | 10/11/2027 | | 3,110 | 0.00% | cash |
| BofA Securities, Inc. | Swaps | 01/11/2027 | | 557 | 0.00% | cash |
| | TOTAL | | | 5,371,394 | 8.15% | |
| TOTAL (A&B) | # of voting rights | % of voting rights |
| | 5,625,998 | 8.54% |
The chain of control has been described at the end of the notification (section 11) and can be found here.
About Lakefront**®**Biotherapeutics
Lakefront Biotherapeutics is a biotechnology company dedicated to building a differentiated pipeline of medicines for patients with serious diseases in areas of high unmet need. The Company has established a clinical‑stage portfolio in immunology and inflammation, anchored by gamgertamig, a potential first‑in‑class and best-in-class BCMAxCD3 T‑cell engager for autoimmune diseases. Backed by deep deal‑making expertise, operational flexibility, and a strong capital position, Lakefront identifies, acquires, and advances high‑quality assets with clear potential to deliver meaningful patient impact and long‑term shareholder value. For more information, visit https://www.lakefrontbio.com or follow us on LinkedIn or X.